Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

11/4/24 11:53:29 AM ET

Investment Managers

Finance

Get the next $HLNE alert in real time by email

SC 13G/A 1 UnitedStates_13G__HamiltonLa.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* (Name of Issuer) Hamilton Lane Inc (Title of Class of Securities) Common Stock (CUSIP Number) 407497106 (Date of Event Which Requires Filing of this Statement) September 30, 2024 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, an* d for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of * the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 407497106 (1) Names of reporting persons The Vanguard Group (2) Check the appropriate box if a member of a group (a) (see instructions) (b) X (3) SEC use only (4) Citizenship or place of organization Pennsylvania Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power 70,593 (7) Sole dispositive power 2,922,909 (8) Shared dispositive power 115,698 (9) Aggregate amount beneficially owned by each reporting person 3,038,607 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 7.49% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: Hamilton Lane Inc Item 1(b) Address of issuer's principal executive offices: 110 Washington Street, Suite 1300 Conshohocken, PA 19004 Items 2(a)-2(c). Name, Address Of principal business office, and Citizenship of* persons filing: The Vanguard Group - 23-1945930 100 Vanguard Blvd. Malvern, PA 19355 2(d) Title of class of securities: Common Stock 2(e) CUSIP Number: 407497106 Item 3. This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). Item 4. Ownership As of the close of business on September 30, 2024: (a) Aggregate amount beneficially owned: 3,038,607 (b) Percent of class: 7.49% (c) Number of shares as to which person has: 1. The Vanguard Group (a) Amount beneficially owned: 3,038,607 (b) Percent of class: 7.49% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 70,593 (iii) Sole power to dispose or to direct the disposition of: 2,922,909 (iv) Shared power to dispose or to direct the disposition of: 115,698 Item 5.Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . Item 6. Ownership of More than 5 Percent on Behalf of Another Person. The Vanguard Group, Inc.'s clients, including investment companies registered u* nder the Investment Company Act of 1940 and other managed accounts, have the ri* ght to receive or the power to direct the receipt of dividends from, or the pro* ceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5* %. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Be

Get the next $HLNE alert in real time by email

Recent Analyst Ratings for

$HLNE

Date	Price Target	Rating	Analyst
4/16/2026	$166.00	Neutral → Overweight	Analyst
12/11/2025	$166.00	Buy	UBS
11/6/2025	$165.00	Neutral → Buy	Goldman
10/14/2025	$181.00	Perform → Outperform	Oppenheimer
10/13/2025	$150.00	Mkt Perform → Outperform	Keefe Bruyette
10/3/2025	$150.00	Outperform	BMO Capital Markets
9/18/2025	$162.00	Sell → Neutral	Goldman
5/15/2025		Outperform → Perform	Oppenheimer

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

11/4/24 11:53:29 AM ET

$HLNE

Investment Managers

Finance

Get the next $HLNE alert in real time by email

Recent Analyst Ratings for

$HLNE

Date	Price Target	Rating	Analyst
4/16/2026	$166.00	Neutral → Overweight	Analyst
12/11/2025	$166.00	Buy	UBS
11/6/2025	$165.00	Neutral → Buy	Goldman
10/14/2025	$181.00	Perform → Outperform	Oppenheimer
10/13/2025	$150.00	Mkt Perform → Outperform	Keefe Bruyette
10/3/2025	$150.00	Outperform	BMO Capital Markets
9/18/2025	$162.00	Sell → Neutral	Goldman
5/15/2025		Outperform → Perform	Oppenheimer

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$HLNE

Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$HLNE

$HLNE
Insider Purchases

Executive Co-Chairman Rogers Hartley R. bought $9,992,338 worth of shares (110,932 units at $90.08) (SEC Form 4)

Director Berkman David J bought $1,010,000 worth of shares (10,000 units at $101.00) (SEC Form 4)

Co-Chief Executive Officer Hirsch Erik R. bought $988,260 worth of shares (9,225 units at $107.13), increasing direct ownership by 15% to 70,494 units (SEC Form 4)

$HLNE
Press Releases

HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes

$HLNE
SEC Filings

Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

SEC Form 10-K filed by Hamilton Lane Incorporated

Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$HLNE
Insider Trading

Chief Operating Officer Kramer Andrea Anigati was granted 3,605 shares, increasing direct ownership by 4% to 86,067 units (SEC Form 4)

Chief Accounting Officer Carl Drew Thomas was granted 675 shares, increasing direct ownership by 58% to 1,846 units (SEC Form 4)

Chief Financial Officer Armbrister Jeffrey Brian was granted 2,109 shares, increasing direct ownership by 19% to 12,958 units (SEC Form 4)

$HLNE
Analyst Ratings

Hamilton Lane upgraded by Analyst with a new price target

UBS resumed coverage on Hamilton Lane with a new price target

Hamilton Lane upgraded by Goldman with a new price target

$HLNE
Leadership Updates

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion

Leading asset managers to join new Corastone platform as investors alongside Apollo, Franklin Templeton and KKR

$HLNE
Large Ownership Changes